Tokyo, Japan

Susumu Higashida


Average Co-Inventor Count = 9.6

ph-index = 7

Forward Citations = 121(Granted Patents)


Location History:

  • Hiro, JA (1976)
  • Tokyo, JA (1976 - 1978)
  • Hiromachi, JP (1980)
  • Tokyo, JP (1978 - 1997)

Company Filing History:


Years Active: 1976-1997

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Susumu Higashida: Innovator in HIV Protease Inhibition

Introduction

Susumu Higashida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit HIV protease. With a total of 11 patents to his name, Higashida's work has the potential to impact the treatment and prevention of AIDS.

Latest Patents

Higashida's latest patents include innovative compounds designed to inhibit the activity of HIV protease. One notable patent describes compounds of formula (I), where various substituents such as R¹, R², R³, R⁴, and R⁵ are defined to enhance the efficacy of these inhibitors. These compounds may be utilized for the treatment and prophylaxis of AIDS. Another patent focuses on piperidine derivatives, which possess a formula that allows for various functional groups, including alkyl and amino groups, to be incorporated, further expanding the therapeutic potential of his inventions.

Career Highlights

Higashida is currently associated with Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding of HIV protease and developing new therapeutic strategies.

Collaborations

Throughout his career, Higashida has collaborated with notable colleagues, including Katsuaki Matsui and Tomoyuki Kurumada. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Susumu Higashida's contributions to the field of HIV protease inhibition exemplify the impact of innovative thinking in pharmaceutical research. His patents and ongoing work at Sankyo Company, Limited, highlight the importance of collaboration and creativity in addressing global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…